Mogamulizumab-kpkc Intravenous and ThyroSafe
Determining the interaction of Mogamulizumab-kpkc Intravenous and ThyroSafe and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: potassium iodide
Brand name: IOSAT, ThyroSafe, ThyroShield, Pima, SSKI
Synonyms: Potassium iodide, Potassium Iodide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-ThyroShield
- Mogamulizumab-kpkc Intravenous-Thyrotropin alfa
- Mogamulizumab-kpkc Intravenous-Thyrotropin alfa Injection
- Mogamulizumab-kpkc Intravenous-Thytropar
- Mogamulizumab-kpkc Intravenous-Ti-Seb Topical
- Mogamulizumab-kpkc Intravenous-Tiadylt ER
- ThyroSafe-Molindone
- ThyroSafe-Mometasone (Oral Inhalation)
- ThyroSafe-Mometasone and Formoterol
- ThyroSafe-Mometasone and formoterol Inhalation
- ThyroSafe-Mometasone Cream
- ThyroSafe-Mometasone Furoate